The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

Insilico Medicine (“Insilico”), a world-leading artificial intelligence (AI)-driven drug discovery company, today announced a ...

The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a ...

The DDU is at the forefront of clinical and translational cancer research and provides a key link between laboratory and clinic. It benefits from its position between the two institutions, allowing ...

Cancer drugs play a crucial role in many patients’ treatment, offering promising improvements in survival and quality of life. There have been exciting advances in drug development over recent years, ...

The Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit is the definitive industry-led forum for drug development in the largest solid tumor indication. This is a strategic conference designed ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

The Cancer/Oncology Drugs Market plays a crucial role in the global healthcare industry, focusing on the development and distribution of pharmaceutical treatments for various types of cancer. Oncology ...

A new analysis exploring the finances of bringing new cancer drugs to market has found that precision oncology drugs could be $1 billion cheaper to develop than non-precision drugs. Despite this, ...

Cancer drug development is a notoriously slow and unforgiving process. Even with decades of progress, nine out of ten experimental treatments still fail to make it through clinical trials. The reasons ...

Up to two in five advanced prostate cancer patients could be treated with a combination of two targeted drugs, according to new research. Findings by a team of scientists at The Institute of Cancer ...